Login / Register for free to get access to My MedWorm

MedPage Today DermatologyMedPage Today Dermatology RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

162 records returned

'Wear Ur SPF' Text Reminders Increase Sunscreen Use (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Using text messages to remind patients to wear their sunscreen may increase their compliance, researchers said. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 17, 2009 Category: Dermatology Source Type: news

ASTRO: Radiation Blocks Recurrence in High-Risk Melanoma (CME/CE, with video)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CHICAGO (MedPage Today) -- Radiation therapy after lymphadenectomy significantly reduced the risk of recurrence in patients with high-risk melanoma, according to a first-of-its-kind randomized clinical trial. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 2, 2009 Category: Dermatology Source Type: news

ASTRO: Radiation Blocks Recurrence in High-Risk Melanoma (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
CHICAGO (MedPage Today) -- Radiation therapy after lymphadenectomy significantly reduced the risk of recurrence in patients with high-risk melanoma, according to a first-of-its-kind randomized clinical trial. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 2, 2009 Category: Dermatology Source Type: news

Residents Lack Skill in Skin Cancer Exams (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Opportunities to learn how to perform skin cancer examinations during medical training are inadequate, with three-quarters of residents reporting never having been taught this skill, a survey found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 20, 2009 Category: Dermatology Source Type: news

ACR: Rheumatoid Arthritis Biologics Increase Risk of Common Skin Cancer (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Rheumatoid arthritis patients being treated with potent tumor necrosis factor inhibitors run an increased risk of developing skin cancer, researchers said here at the American College of Rheumatology's annual meeting. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 19, 2009 Category: Dermatology Source Type: news

EADV: Psoriasis Comorbidities May Cut Longevity (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- Psoriasis patients have a substantial comorbidity burden that can reduce life expectancy by 10 years or more, according to data presented here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 14, 2009 Category: Dermatology Source Type: news

EADV: Benefit of Methrotrexate in Psoriasis Will Show Up Early (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- A suboptimal response to methotrexate at 12 weeks identified psoriasis patients who were unlikely to benefit from continued therapy at higher doses, a retrospective analysis of clinical-trial data showed. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 14, 2009 Category: Dermatology Source Type: news

EADV: Agent Clears Lesions, Lessens Psoriatic Arthritis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- In patients with psoriasis and concomitant psoriatic arthritis, treatment with etanercept (Enbrel) improved skin lesions, enthesitis, and dactylitis in a majority of patients, data from a randomized clinical trial showed. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 14, 2009 Category: Dermatology Source Type: news

EADV: Anti-TNF Exposure Does Not Rule out TNF Inhibitor for Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- Prior exposure to anti-tumor necrosis factor (TNF) therapy does not rule out potential benefits from additional anti-TNF therapy for patients with psoriasis, according to data presented here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 13, 2009 Category: Dermatology Source Type: news

EADV: Cytokine Inhibitor Has High Psoriasis Response (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- More than 80% of patients with moderate to severe psoriasis had major responses to an investigational interleukin inhibitor, investigators reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 12, 2009 Category: Dermatology Source Type: news

EADV: Interleukin Inhibitor Works Across Psoriasis Subgroups (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- A newly approved cytokine inhibitor demonstrated consistent activity across a range of psoriasis patient subgroups and showed no loss of efficacy in heavier patients with appropriate dosing, according to data reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 12, 2009 Category: Dermatology Source Type: news

EADV: Systemic Psoriasis Therapy Often Delayed (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- Patients with psoriasis resistant to topical therapy frequently wait a year or longer to receive systemic therapy, investigators reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 12, 2009 Category: Dermatology Source Type: news

EADV: High Rate of Metabolic Syndrome in Psoriasis Patients (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- More than half of patients with psoriasis met diagnostic criteria for metabolic syndrome and had a high prevalence of associated risk factors, according to data from a small cohort study. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 9, 2009 Category: Dermatology Source Type: news

EADV: TNF Inhibitor Active in Palmoplantar Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- Patients with palmoplantar psoriasis had at least 50% improvement after 14 weeks when treated with a tumor necrosis factor (TNF) inhibitor, according to results of a small clinical trial reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 9, 2009 Category: Dermatology Source Type: news

EADV: Scalp, Nail Psoriasis Improve with TNF Inhibitor (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
BERLIN (MedPage Today) -- Treatment with a tumor necrosis factor (TNF) inhibitor significantly improved scalp and nail psoriasis as well as skin lesions, according to a retrospective analysis of a randomized clinical trial. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 9, 2009 Category: Dermatology Source Type: news

Heparin Lesions More Common than Expected (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Subcutaneous heparin will induce skin lesions in about one in 13 patients, usually as a result of an allergic reaction, German researchers said. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 29, 2009 Category: Dermatology Source Type: news

ECCO-ESMO: No Melanoma Survival Benefit with Targeted Agent (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Bevacizumab (Avastin) failed to improve survival in advanced melanoma when added to carboplatin and paclitaxel, results of a randomized, multicenter clinical trial showed. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 25, 2009 Category: Dermatology Source Type: news

FDA Approves Biologic Drug for Psoriasisemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
After nearly two years of deliberations, the FDA has finally approved ustekinumab (Stelara) for moderate to severe plaque psoriasis. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 25, 2009 Category: Dermatology Source Type: news

Lax Tanning Policies for Kids May Increase Melanoma Risk (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
A majority of tanning facilities would allow a teenager to tan every day for a week straight, against FDA recommendations, researchers say. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 21, 2009 Category: Dermatology Source Type: news

FDA Panel Gives Nod to Two Cancer Drugsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
WASHINGTON (MedPage Today) -- An FDA advisory panel on Wednesday recommended the agency approve two investigational drugs to treat two uncommon types of non-Hodgkin's lymphoma. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 3, 2009 Category: Dermatology Source Type: news

Drug Shows Activity in Advanced Basal-Cell Cancer (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
More than half of patients with advanced or metastatic basal-cell cancer had major responses when treated with a drug that targets the hedgehog pathway of growth regulation. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 2, 2009 Category: Dermatology Source Type: news

Psoriasis Patients' Brains Filter Disgusted Looks (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The brains of patients with psoriasis are less responsive to expressions of disgust on other people's faces, a neurological device that may help them cope with the social stigma of the disease, a new study found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 27, 2009 Category: Dermatology Source Type: news

Full-body skin exams detect early skin cancer (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Dermatologists conducting full-body skin exams are better at detecting skin cancers than are patients themselves, especially in the case of early-stage melanomas that have not invaded below the surface of the skin, a new study found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 17, 2009 Category: Dermatology Source Type: news

Antioxidants Pose No Melanoma Risk (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Antioxidant supplementation did not increase the risk of melanoma in men or women, analysis of data from a population study of almost 70,000 participants showed. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 17, 2009 Category: Dermatology Source Type: news

MRSA Is Culprit in Higher Hospitalization Rateemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Methicillin-resistant Staphylococcus aureus (MRSA) appears to be driving an increase in the number of people hospitalized with skin and soft tissue infections, researchers found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 14, 2009 Category: Dermatology Source Type: news

Diarrhea with Novel Drug Not Prevented by Corticosteroid (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Prophylactic corticosteroid treatment may not prevent moderate to severe diarrhea reactions with the novel monoclonal antibody ipilimumab for advanced melanoma, researchers found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 13, 2009 Category: Dermatology Source Type: news

Beta-blocker Quickly Combats Hemangiomas (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The beta-blocker propranolol appears to be an effective and well-tolerated treatment for infantile hemangiomas, according to a new case series in Pediatrics. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 10, 2009 Category: Dermatology Source Type: news

FDA Warns of Pediatric Cancer Risk with TNF Blockersemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
WASHINGTON (MedPage Today) -- The FDA called for stronger warnings in prescribing information for tumor necrosis factor (TNF) blockers to highlight a greater risk of cancer in children and adolescents. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - August 4, 2009 Category: Dermatology Source Type: news

Chemo Drug Repairs Sun-Damaged Skin (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
TORONTO (MedPage Today) -- Topical application of the chemotherapy drug fluorouracil, or 5FU, can significantly restore sun-damaged skin, researchers said. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - June 15, 2009 Category: Dermatology Source Type: news

ASCO: Vaccines Create Buzz but HER-2 in Stomach Cancer May Change Practiceemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
ORLANDO (MedPage Today) -- A pair of investigational therapeutic cancer vaccines -- one for lymphoma and the other for melanoma -- highlight this MedPage Today InFocus discussion. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - June 2, 2009 Category: Dermatology Source Type: news

ICD: Antibodies to Infliximab at Play in Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- A third of psoriasis patients treated with infliximab (Remicade) developed antibodies to the agent, which correlated with loss of activity and worsening disease severity, a small clinical study showed. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - June 1, 2009 Category: Dermatology Source Type: news

ICD: Herpes Virus Linked to Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- More than half of a group of patients with psoriasis tested positive for human herpes virus 8 (HHV-8), suggesting infection might play a role in the etiology of the disease, according to data reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - June 1, 2009 Category: Dermatology Source Type: news

ASCO: Vaccine Trains Killer Cells to Battle Melanomaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
ORLANDO (MedPage Today) -- A vaccine approach that trains immune cells and sends them marching into battle has shown promise in advanced melanoma, a researcher said here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 31, 2009 Category: Dermatology Source Type: news

ICD: Trace Elements May Have Role in Psoriasis Management (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- An imbalance in trace metals in the body may contribute to the pathogenesis of psoriasis, according to data reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 31, 2009 Category: Dermatology Source Type: news

ICD: Steroid-Sparing Treatment Shows Promise for Alopecia (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- Methotrexate-based, steroid-sparing therapy has induced hair growth in more than 90% of patients with alopecia universalis, according to an ongoing clinical evaluation. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 29, 2009 Category: Dermatology Source Type: news

ICD: Diabetes Drug May Aid Psoriasis Control (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- The diabetes drug pioglitazone significantly improved psoriasis control when added to oral acitretin (Soriatane), data from a small clinical trial demonstrated. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 28, 2009 Category: Dermatology Source Type: news

ICD: Coal Tar Still Viable for Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- For psoriasis patients who can handle the smell and mess, coal tar remains an effective, inexpensive treatment option for stable disease, investigators concluded. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 27, 2009 Category: Dermatology Source Type: news

ICD: Biology-Psyche Link Explored in Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- A mind-body connection may play a role in psoriasis patients' adaptation to the chronic disease, data from a Polish study suggest. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 27, 2009 Category: Dermatology Source Type: news

ICD: Cytokine Levels May Offer Psoriasis Clues (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- Monitoring cytokine levels in patients with psoriasis may offer an early indication of response to therapy, according to data reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 27, 2009 Category: Dermatology Source Type: news

ICD: Palmoplantar Psoriasis Responds to Retinoid (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- Treatment with the oral vitamin A derivative acitretin (Soriatane) led to measurable improvement in 100% of patients with palmoplantar psoriasis in a small clinical series reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 27, 2009 Category: Dermatology Source Type: news

ICD: Silica Spheres Enhance Acne Drug (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- Silica-encapsulated benzoyl peroxide led to significantly greater improvement in acne with less skin irritation compared with a conventional form of the medication, according to results of a randomized clinical trial. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 22, 2009 Category: Dermatology Source Type: news

ICD: Hands Down -- Oral Retiniod Trumps Topical Steroids (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- Almost half of patients with steroid-resistant hand eczema had complete or near-complete clearance when treated with the vitamin D analog alitretinoin, according to data from two clinical trials. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 22, 2009 Category: Dermatology Source Type: news

ICD: Idiopathic Erythroderma May Signal Undiagnosed Cancer (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
PRAGUE (MedPage Today) -- Unexplained erythema should raise suspicion about a possible underlying malignancy, according to investigators who found cancer associated with more than 20% of cases of idiopathic erythroderma. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 21, 2009 Category: Dermatology Source Type: news

SID: Topical 5-FU Helps Heal Photoaged Skin (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MONTREAL (MedPage Today) -- Topical 5-fluorouracil for the treatment of actinic keratoses can also promote dermal remodeling in photoaged skin, according to Dr. Sewon Kang, from Johns Hopkins University. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 13, 2009 Category: Dermatology Source Type: news

SID: Study Links Skin, Psychiatric Problems (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MONTREAL (MedPage Today) -- People who report skin problems of any kind are also significantly more likely to experience depression, anxiety, or psychosis, according to a report at the annual meeting of the Society for Investigative Dermatology. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 13, 2009 Category: Dermatology Source Type: news

SID: Vitamin D3 May Protect Against Nonmelanoma Skin Cancer (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MONTREAL (MedPage Today) -- Higher serum levels of vitamin D3 were associated with a decreased risk of nonmelanoma skin cancer, researchers found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 13, 2009 Category: Dermatology Source Type: news

SID: Beer Consumption Increases Risk of Psoriasis (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MONTREAL (MedPage Today) -- Women who drink beer -- but not other types of alcohol -- are more likely to develop psoriasis than other women, researchers found. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 12, 2009 Category: Dermatology Source Type: news

SID: COX-2 Inhibitors May Cut Skin Cancer Rate (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MONTREAL (MedPage Today) -- A twice-daily dose of celecoxib (Celebrex) over a period of nine months reduced the incidence of nonmelanoma skin cancer by almost 60 percent, according to the results of a new study. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 12, 2009 Category: Dermatology Source Type: news

SID: Melanoma in U.S. Shows Rapid Increase (CME/CE)email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
MONTREAL (MedPage Today) -- The incidence of melanoma in the U.S. increased rapidly over a 12-year period -- across socioeconomic lines and for all tumor thicknesses -- according to a study reported here. (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 11, 2009 Category: Dermatology Source Type: news